Results 101 to 110 of about 156,885 (296)

Heterotopic Pancreas in the Stomach Masquerading Neoplasm

open access: yesJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014
A 36-year-old male was referred to our hospital with a diagnosis of adenocarcinoma stomach on endoscopic biopsy while routinely being evaluated for acid peptic disease. Patient had past episodes of epigastric pain and nausea. The physical examination findings, routine blood tests and abdominal ultrasonography were unremarkable.
Manas R Baisakh   +4 more
openaire   +3 more sources

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling

open access: yesFEBS Open Bio, EarlyView.
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero   +5 more
wiley   +1 more source

A Large Gastric Inflammatory Fibroid Polyp

open access: yesGE: Portuguese Journal of Gastroenterology, 2015
Inflammatory fibroid polyp (IFP) is an unusual benign gastrointestinal subepithelial tumor (SET). The endosonographic (EUS) features of IFPs were sporadically reported on imaging tips or small case series study.
Teresa Pinto-Pais   +7 more
doaj   +1 more source

Evaluation of specific biochemical indicators of Helicobactepylori-associated gastric cancer in Egypt

open access: yes, 2012
501-507The aim of the study was to assess the accuracy of some specific biochemical indicators in discriminating between Helicobacter pylori-associated gastritis and H.
Anwar, M.M.   +5 more
core  

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH‐SY5Y and U‐87 MG cancer cells

open access: yesFEBS Open Bio, EarlyView.
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar   +4 more
wiley   +1 more source

Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms

open access: yes, 2013
The adenomatous polyposis coli gene is a key tumor suppressor gene. Alterations in this gene have been found in most sporadic colon cancers; associated with familial adenomatous polyposis; and found in neoplasms of other organs, such as the liver ...
Rindi, Guido   +7 more
core   +1 more source

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

open access: yesFEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin   +12 more
wiley   +1 more source

Lymphosarcoma of the Stomach: A Case Report.

open access: yes, 1977
A case of lymphosarcoma of the stomach which was diagnosed pre-operatively by biopsy of a supraclavicular lymph node.Lymphosarcoma of the stomach is a rare, forming 1 to 5% of the total gastric neoplasms (AIIen et al.
Mampilly, J.
core  

Clinical significance of colonoscopy in patients with upper gastrointestinal polyps and neoplasms: a meta-analysis.

open access: yes, 2014
BACKGROUND: Some authors have studied the relationship between the presence of polyps, adenomas and cancers of upper gastrointestinal tract (stomach and duodenum) and risk of colorectal polyps and neoplasms; however, the results are controversial, which ...
Jun-Gang Liu   +9 more
core   +1 more source

Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance

open access: yesAging and Cancer, EarlyView.
NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy